COVID-19 and Cardiac Arrhythmias: a Contemporary Review
- 19 April 2022
- journal article
- review article
- Published by Springer Nature in Current Treatment Options in Cardiovascular Medicine
- Vol. 24 (6) , 87-107
Abstract
Purpose of Review A significant proportion of patients infected by the severe acute respiratory syndrome-coronavirus (SARS-CoV2) (COVID-19) also have disorders affecting the cardiac rhythm. In this review, we provide an in-depth review of the pathophysiological mechanisms underlying the associated arrhythmic complications of COVID-19 infection and provide pragmatic, evidence-based recommendations for the clinical management of these conditions. Recent Findings Arrhythmic manifestations of COVID-19 include atrial arrhythmias such as atrial fibrillation or atrial flutter, sinus node dysfunction, atrioventricular conduction abnormalities, ventricular tachyarrhythmias, sudden cardiac arrest, and cardiovascular dysautonomias including the so-called long COVID syndrome. Various pathophysiological mechanisms have been implicated, such as direct viral invasion, hypoxemia, local and systemic inflammation, changes in ion channel physiology, immune activation, and autonomic dysregulation. The development of atrial or ventricular arrhythmias in hospitalized COVID-19 patients has been shown to portend a higher risk of in-hospital death. Summary Arrhythmic complications from acute COVID-19 infection are commonly encountered in clinical practice, and COVID-19 patients with cardiac complications tend to have worse clinical outcomes than those without. Management of these arrhythmias should be based on published evidence-based guidelines, with special consideration of the acuity of COVID-19 infection, concomitant use of antimicrobial and anti-inflammatory drugs, and the transient nature of some rhythm disorders. Some manifestations, such as the long COVID syndrome, may lead to residual symptoms several months after acute infection. As the pandemic evolves with the discovery of new SARS-CoV2 variants, development and use of newer anti-viral and immuno-modulator drugs, and the increasing adoption of vaccination, clinicians must remain vigilant for other arrhythmic manifestations that may occur in association with this novel but potentially deadly disease.Keywords
This publication has 72 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm SocietyCirculation, 2019
- 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summaryHeart Rhythm, 2018
- 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With SyncopeJACC, 2017
- Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritisEuropean Heart Journal, 2016
- Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: A meta-analysisInternational Journal of Cardiology, 2013
- The Angiotensin-(1-7)/Mas Receptor Axis Is Expressed in Sinoatrial Node Cells of RatsJournal of Histochemistry & Cytochemistry, 2011
- Cardiovascular complications of severe acute respiratory syndromePostgraduate Medical Journal, 2006
- Blockade of Currents by the Antimalarial Drug Chloroquine in Feline Ventricular MyocytesThe Journal of Pharmacology and Experimental Therapeutics, 2001
- Plasma Concentrations of Haloperidol and Prolactin and Clinical Outcome in Acutely Psychotic PatientsPharmacopsychiatry, 1988